
Robert Weisman
Staff Writer at The Boston Globe
Staff writer @BostonGlobe and https://t.co/21fqgjdUcv. Tracking biotech and the life sciences wave washing over Massachusetts.
Articles
-
1 week ago |
bostonglobe.com | Robert Weisman
The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, effective next Jan. 1, citing rapidly rising costs that are burdening insurers and employers. Under its new policy, Blue Cross Blue Shield of Massachusetts will continue to cover the costly medications, known as GLP-1s, in its standard health benefits when they’re prescribed for diabetes.
-
1 week ago |
bostonglobe.com | Robert Weisman
Like tens of thousands of Massachusetts residents, community college professor Carolyn McGrath has been paying for medicine for decades. McGrath, 53, was diagnosed with type 1 diabetes when she was 11. For years, before she could afford health insurance, she spent up to $300 a month for insulin. McGrath would stock up on lower-priced insulin on trips to Canada. These days, she buys a generic version for $35 a month through insurance.
-
1 week ago |
bostonglobe.com | Jonathan Saltzman |Robert Weisman
Shortly after the federal government froze $2.2 billion in federal funding to Harvard University for defying a slew of government demands, the head of Mass General Brigham said officials at the Harvard-affiliated health system believe the funding freeze shouldn’t apply to MGB.
-
2 weeks ago |
bostonglobe.com | Robert Weisman
Life sciences companies in Massachusetts were heartened by a single word in a Trump administration fact sheet about its new reciprocal tariffs: “Pharmaceuticals” were included on a short list — along with copper, semiconductors, and lumber — of goods exempted.
-
3 weeks ago |
bostonglobe.com | Robert Weisman
Chief operating officer Maggie O’Toole, who was employee No. 1 when LabCentral launched in 2013, will take over as CEO on May 1. LabCentral’s cofounder Joannes Fruehauf, the chief executive for the past 12 years, will take a new role as executive chairman. LabCentral companies have raised more than $20 billion in funding and created more than 7,000 jobs in Massachusetts since its founding.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 3K
- Tweets
- 3K
- DMs Open
- No